TY - JOUR AU - Lange, Marie AU - Joly, Florence PY - 2017 TI - Cognitive complaints in breast cancer patients treated with chemotherapy: a reality? JF - Translational Cancer Research; Vol 6, Supplement 3 (May 26, 2017): Translational Cancer Research Y2 - 2017 KW - N2 - Memory and attention dysfunction is a common complaint among cancer survivors, named “chemobrain”, which can be reported during and even several years after treatment. These disorders have a negative impact on patients’ quality of life (1) and can disturb ability to work (2). Recent studies assessed self-reported cognitive function in cancer patient cohorts, mainly in breast cancer women, and showed that 46% to 60% of survivors had cognitive complaints (3-5). However, these studies did not use a validated questionnaire specifically constructed to assess cognitive complaints. UR - https://tcr.amegroups.org/article/view/13012